Case-Based Roundtables on TargetedOnc.com are collaborative, small-group discussions about case-based clinical profiles and engaging peer-dialogue led by an expert physician. These resources offer practicing oncologists and hematologists insight on relevant data, treatment strategies, and varying professional opinions.

LATEST LEUKEMIAS CONTENT

Thinking Beyond Efficacy When Selecting BTK Inhibitors in Relapsed CLL

Oncologists Weigh Frontline BTK Inhibitor Strategies in CLL

Evolving Approaches to BTK Inhibitor Therapy in CLL

Experts Weigh Fixed-Duration Approaches in Frontline CLL

Individualizing Fixed-Duration Therapy in Treatment-Naive CLL

Experts Consider New Data, New BTKi Choices in Frontline CLL

Imetelstat Improves Outcomes in Heavily Transfusion-Dependent MDS

Duration of Response Contributes to Survival in COMMANDS Trial in MDS

CASE-BASED ROUNDTABLES

Patients With Treatment-Naive CLL Treated With BTK Inhibition

October 17, 2023

Frontline and Subsequent Therapies for Chronic Lymphocytic Leukemia

Treating CLL With Bruton Tyrosine Kinase Inhibitors

October 29, 2021